MedTrace Logo

Healthy Term Infants Fed Milk-Based Infant Formula

NCT04529759 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2021-07-15

No results posted yet for this study

Summary

This is a randomized, controlled, double-blind, parallel, feeding study with the purpose to evaluate the tolerance of healthy term infants fed partially hydrolyzed whey protein infant formulas.

Conditions

  • Tolerance

Interventions

OTHER

Control Infant Formula

Powdered partially hydrolyzed whey (WPH) based formula with an oligosaccharide

OTHER

Experimental Infant Formula

Powdered partially hydrolyzed whey (WPH) based formula with oligosaccharides blend

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • John Lasekan, PhD · Abbott Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-12
Primary Completion
2021-06-18
Completion
2021-06-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04529759 on ClinicalTrials.gov